Agile, Data-Driven Life Cycle Management for Continuous Manufacturing
ISPE
JULY 6, 2023
1 , 4 A Retrospective Journey In 2015, Vertex’s Orkambi was the first approved drug produced under a CM process for the treatment of cystic fibrosis. Published August 2009. This is demonstrated by the rise from $1.05 billion US in 2021 to $1.9 billion US in 2022 for the global market share for prescription drugs produced using CM.
52 
Let's personalize your content